ABSTRACT
The Women's Health Care Committee was established in 2010 to promote women's health. In the fiscal year 2025, the committee advanced research and initiatives with a view toward social implementation, focusing on advancing understanding of disease etiology and improving quality of life (QOL) across the entire female life course, from adolescence to reproductive years, menopause, and older age. This year, nine subcommittees were established, which addressed a broad spectrum of topics, including menopausal disorders and occupational issues, pelvic floor dysfunction during the perinatal period, cancer and sexual education in adolescence, long‐term management of Turner syndrome, menstrual disorders, and awareness of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). In addition, emerging areas such as trace elements and supplements, telemedicine, and nutritional assessments have also been explored. Furthermore, cross‐cutting discussions were conducted beyond individual diseases and clinical domains, encompassing challenges in healthcare delivery systems, educational frameworks, and the broader social context of women's healthcare. This report is based on the Japanese version of the annual report (Acta Obstetrica et Gynaecologica Japonica 2026; 78(6): 925–930).
Keywords: adolescent cancer, menopausal disorders, occupational health, pelvic floor dysfunction, telemedicine and nutritional assessment
1. Subcommittee on the Survey of the Clinical Management of Menopausal Disorders in Working Women in Japan
Subcommittee Chairperson: Mariko Ogawa
Subcommittee Members: Kiyoshi Takamatsu, Hiroya Okano, Miho Iida, Akiko Yamaguchi, and Riyo Kiuchi
1.1. Background and Objective
Menopausal disorders contribute to reduced workplace performance and job resignation among working women and have been reported to cause considerable losses to the Japanese economy. However, little is known about how obstetricians and gynecologists manage working women with menopausal disorders. Clarifying the current state of clinical practice and its challenges is essential for improving the quality of life of menopausal women. Therefore, this subcommittee conducted a web‐based survey of the members of the Japan Society of Obstetrics and Gynecology (JSOG).
1.2. Subjects and Methods
Following approval from the Ethics Committee of Fukushima Medical University, a link to the web‐based questionnaire was sent to the JSOG members via email. Eligible respondents were JSOG member obstetrician‐gynecologists engaged in clinical practice during the study period, and valid responses were obtained from 919 physicians. The data were statistically analyzed.
1.3. Main Results
1.3.1. Quantitative Analysis
Kampo (Japanese herbal) medicine and hormone replacement therapy were provided by nearly all respondents as treatments for menopausal disorders.
Regarding working women with menopausal disorders, 89.4% of respondents had seen patients reporting reduced work performance due to menopausal symptoms; 57.8% had seen patients who had been absent from work, and 29.8% had seen patients who had resigned. Meanwhile, 82.4% reported having seen patients whose work performance improved with treatment, suggesting the effectiveness of appropriate therapeutic interventions.
More than half of the respondents answered that they had “little” or “no” opportunity to acquire knowledge on menopausal care before obtaining board certification in obstetrics and gynecology. This suggests that menopausal medicine has not been sufficiently addressed in postgraduate education.
The most frequently cited difficulty in managing menopausal disorders was “the diversity of symptoms,” followed by “the time required for consultation.” The median consultation time for menopausal symptoms was 20 min for initial visits and 10 min for follow‐up visits, both of which were significantly longer than for dysmenorrhea.
1.3.2. Qualitative Analysis
Free‐text responses regarding challenges and opinions on gynecological care for menopausal disorders were coded and analyzed qualitatively. The most common opinion was the need to revise the medical service fees, including additional reimbursements. Because menopausal symptoms are diverse and often include psychological complaints requiring attentive listening, consultations take considerable time; however, the current fee schedule makes adequate care difficult. At the same time, many gynecologists found the care of menopausal symptoms rewarding and important, and called for a systematic training program beginning at the resident stage, stronger multidisciplinary collaboration, and awareness‐raising activities for the general female population.
1.4. Future Plans
Based on these results, the subcommittee will consider developing a tool to support the clinical management of menopausal disorders in working women.
2. Subcommittee on the Survey of Incidence of Lower Urinary Tract Symptoms and Pelvic Floor Dysfunction During Postpartum Period in Japanese Women
Subcommittee Chairperson: Tsuyoshi Higuchi
Subcommittee Members: Toshio Igarashi, Tomoe Inoue (Hirakawa), Takeya Kitta, Daisuke Tachibana, Maki Nakata, Kanako Yoshida, and Mikako Yoshida
2.1. Background and Objectives
Female lower urinary tract symptoms (FLUTS) and pelvic organ prolapse (POP) are generally perceived as conditions that affect middle‐aged and older women. However, related symptoms, such as those triggered by vaginal delivery and childbirth, are well established as major risk factors for developing these conditions later in life. However, the actual prevalence and status of symptom manifestations during pregnancy and the postpartum period in Japan remain poorly understood. This study aimed to investigate the status of pelvic floor dysfunction, including defecation and sexual dysfunction, during the postpartum period.
2.2. Progress Status
The subcommittee initially focused on selecting an appropriate survey instrument. We adopted the Australian Pelvic Floor Questionnaire (APFQ), a self‐administered questionnaire consisting of 42 items comprehensively covering urinary and bowel issues, POP, and sexual dysfunction, and translated it into Japanese by the subcommittee. The study was initiated after receiving approval from the Ethics Committee of Tokushima University Faculty of Medicine. After completion of the face validity check for the Japanese version of the APFQ, the survey was administered to 620 women of reproductive age (ranging from 18 to 45 years). Preliminary data aggregation on urinary, bowel, and POP and sexual function issues revealed that 29.7%, 12.4%, 9.8%, and 6.8% of the respondents had a history of symptoms (including current symptoms), respectively.
2.3. Future Plans
We conducted a detailed analysis of the questionnaire results. In particular, we will investigate the correlations between symptom onset and factors such as pregnancy, delivery, and the postpartum period.
3. Report on the Activities of the Subcommittee for Supporting Cancer Education and Sex Education in Adolescence, Under the Women's Healthcare Committee
Subcommittee Chairperson: Yasuhito Kato
Subcommittee Members: Kayoko Katayama, Kei Kawana, Hideya Sakakibara, Atsuko Shiota, Chikako Tono, Emiko Nishioka, Yuko Yokohama, and Yuka Wada
This committee began its activities this fiscal year.
In April 2026, we considered the survey items for a questionnaire survey conducted among members of the Japan Society of Obstetrics and Gynecology and concurrently submitted an application to the Ethics Committee for the commencement of the questionnaire survey.
The survey was conducted from April to May 2026 and the analysis results are scheduled to be reported at the 2027 Annual Meeting of the Japan Society of Obstetrics and Gynecology.
4. Subcommittee on Health Management for Turner Syndrome
Subcommittee Chairperson: Kenjiro Sawada
Subcommittee Members: Masanobu Kawai, Mahiru Kawano, Yuriko Kitajima, Hiroko Komura, Shin Saito, and Seido Takae
4.1. Objectives
There are various issues in the healthcare management of women with Turner syndrome. In addition to long‐standing concerns, such as how the diagnosis is made and communicated, and the transition of care from pediatric to adult medicine, recent advances in reproductive medicine have brought new challenges to clinical medicine. This includes fertility preservation, pregnancies through oocyte donation, and the obstetric management of patients with Turner syndrome. Therefore, this study aimed to evaluate the clinical care provided to patients with Turner syndrome. The following two surveys will be conducted in 2025.
4.1.1. Survey on the Actual Clinical Care of Women With Turner Syndrome
4.1.1.1. Method
Detailed clinical information for women with Turner syndrome was registered for each case via an online form at the committee's affiliated institutions (Osaka University, Ehime University, Nagasaki University, Yokohama City University Medical Center, St. Marianna University, and the Osaka Women's and Children's Hospital) and their actual care was surveyed. This study underwent ethical review at each institution, including Osaka University Hospital (Osaka University Hospital Observational Research Ethics Committee approval number: 24222(T4)‐3). The survey focused on the following 10 main items and more detailed sub‐questions: (1) age at diagnosis, (2) age at initial visit, (3) karyotype (with details, if known), (4) reasons for diagnosis, (5) height and weight, (6) consultations with other specialties, (7) regularly performed tests, (8) complications, (9) growth hormone replacement therapy, and (10) female hormone replacement therapy.
4.1.1.2. Results
Data of 95 patients were collected across five institutions. Of these, 22% had the 45X karyotype and most cases were diagnosed by the age of 20. Both growth hormone and female hormone replacement therapies were administered in > 70% of the cases. This study has clarified the current state of care for Turner syndrome at high‐volume centers.
4.1.1.3. Discussion and Future Directions
A more detailed analysis will be conducted and submitted to a journal in the future. In FY 2026, a questionnaire survey was administered to members of the Japan Society of Obstetrics and Gynecology regarding the management of complications, obstetric care in women with Turner syndrome, and the status of the transition from pediatrics to obstetrics and gynecology.
4.1.2. Survey on the Current State of Fertility Preservation for Women With Turner Syndrome
4.1.2.1. Method
An online questionnaire was sent to 630 certified ART facilities by the Japan Society of Obstetrics and Gynecology to assess the experience and intention of the facilities to preserve fertility in women with Turner syndrome. The Osaka University Hospital Observational Research Ethics Committee approved this study (approval number: 24222(T4)‐3). The main topics were as follows: (1) cases of ovarian or oocyte cryopreservation for fertility preservation in Turner syndrome; (2) facilities that have performed fertility preservation procedures: age at the time of the procedure, key considerations in implementing the procedure, whether explanations regarding obstetrical outcomes were given; and (3) future directions of fertility preservation: Would the facility provide the procedure upon patient request? For what kinds of cases should the procedure be performed?
4.1.2.2. Results
Responses were received from 95 (15%) of the 630 facilities. Among them, six facilities (7.4%) reported cases with ovarian or oocyte cryopreservation for fertility preservation purposes. Specifically, ovarian cryopreservation was performed at one facility and oocyte cryopreservation at five, with one to four oocytes frozen per case. In contrast, 55 facilities (57%) indicated a willingness to provide fertility preservation upon patient request. Facilities that chose not to offer it cited reasons such as insufficient counseling resources. The top three factors considered important when performing fertility preservation were (1) the patient's strong desire, (2) expectance of successful oocyte retrieval, and (3) management of complications.
4.1.2.3. Discussion and Future Directions
Although responses were collected from 95 facilities, only six had actually performed fertility preservation, while 57% of the facilities stated that they would provide it if requested. Most of the 535 nonresponding facilities might not have performed fertility preservation; thus, careful interpretation is needed. Given this situation, it is necessary for academic societies to organize the current evidence regarding fertility preservation in patients with Turner syndrome.
This includes determining which cases and timing are appropriate for fertility preservation, what information should be provided before fertility preservation, and so on. Therefore, in FY 2026, we planned to collect and summarize evidence on fertility preservation in patients with Turner syndrome with a view to developing future guidelines.
5. A Survey on the Use of Over‐the‐Counter (OTC) Drugs, Health Foods, and Dietary Supplements in Obstetrics and Gynecology Practice
Subcommittee Chairperson: Taisuke Mori
Subcommittee Members: Fumitake Ito, Kanae Ogawa, Hiroshi Sasaki, and Megumi Yokota
5.1. Background
Trace elements such as iron and zinc play important roles in women's health. However, data on the recommended intake levels for the Japanese population are still limited, and the relationship between trace element imbalances and gynecological conditions across different life stages remains unclear. However, the actual status of supplement use among patients is not well understood.
5.2. Participants and Methods
A questionnaire survey was conducted among JSOG members to investigate the current practices in trace element measurements and supplement use. The study protocol was approved by the Institutional Review Board on March 18, 2026.
5.3. Current Status
The survey was launched on May 12, 2026, via the JSOG website and mailing list. Data collection is currently ongoing. As the response rate is not yet sufficient, further outreach is planned to encourage participation.
6. Subcommittee on the Investigation and Review of Menstrual Disorders in Japanese Women
Subcommittee Chairperson: Haruhiko Kanasaki
Subcommittee Members: Miho Egawa, Satoko Osuka, Aki Oride, Naomi Senba, Masakazu Terauchi, Toshiya Matsuzaki, and Kiyonori Miura
Collaborators: Koji Kugu and Hiroki Noguchi
The “Subcommittee on the Investigation and Review of Menstrual Abnormalities in Japanese Women” plans to conduct research on: (1) redefining normal menstruation in Japanese women, (2) menstruation and menstrual cycle variations in young women from menarche to sexual maturity, and (3) Changes in menstruation from menarche to menopause. Questionnaire surveys will be conducted, targeting women who conceived naturally, young women, and postmenopausal women. After obtaining research approval from Shimane University, the subcommittee held three meetings at the end of the previous year to finalize the survey content and sent a request for cooperation to all members in January of the same year. The questionnaire survey period ran through August of this year, followed by data analysis. The total duration of this research project is set to May 31, 2027.
7. Development and Dissemination of Patient‐Oriented Educational Materials Based on the Japanese Clinical Guidance for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Subcommittee Chairman: Zen Watanabe
Subcommittee Members: Ayumi Okada, Mariko Ogawa, Wakana Kosaki, Yoko Sagara, Takashi Takeda, and Fujiko Miyahara
Collaborators: Akiko Nanri and Sayaka Matsubara
7.1. Background and Objectives
A nationwide survey conducted by our committee during the fiscal years 2021–2022 revealed that many obstetricians and gynecologists in Japan diagnosed premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) primarily based on clinical interviews rather than systematic prospective assessments. Furthermore, a considerable proportion of cases were managed with treatments that did not necessarily align with evidence‐based recommendations.
In response to these findings, the committee developed the Clinical Practice Guidance for the Diagnosis and Management of PMS and PMDD during the fiscal years 2023–2024 to support appropriate clinical decision‐making in routine gynecological practice.
Public awareness of PMS and PMDD has gradually increased in Japan, partly due to the expansion of femtech‐related initiatives. However, an overall understanding of this phenomenon remains insufficient. Effective management of PMS and PMDD requires not only appropriate medical care but also adequate understanding by patients, their families, and the society at large. Therefore, patient education is essential for comprehensive care.
In other medical fields, patient‐oriented educational materials corresponding to professional guidance have been widely used for patient education and public awareness. We believe that similar materials for PMS and PMDD will be beneficial for both healthcare providers and patients.
Accordingly, our subcommittee aimed to develop patient‐oriented educational materials based on recently established clinical guidance and to promote awareness and dissemination of accurate information on PMS and PMDD.
7.2. Activities in FY 2025
In developing patient‐oriented educational content, we incorporated input not only from obstetricians and gynecologists, but also from multidisciplinary professionals, including pediatricians, midwives, pharmacists, and registered dietitians. This approach ensures both medical accuracy and accessibility for the general public.
In addition, consensus meetings were held at academic conferences of related societies, where multidisciplinary participants, including pediatricians, psychiatrists, nurses, and pharmacists, engaged in comprehensive discussions on the content and structure of educational materials.
One such initiative was conducted at the following meeting:
The 44th Annual Meeting of the Japan Society of Adolescent Health
(August 30, 2025, Asahikawa, Japan)
Committee Session:
“Toward the Development of Patient‐Oriented PMS/PMDD Management Materials: Perspectives from Adolescent Health Professionals”.
7.3. Future Plans
We plan to complete the development of patient‐oriented educational materials by the fiscal year 2026 and publish them on the official website of the Japan Society of Obstetrics and Gynecology.
In addition to web‐based dissemination, printed materials will be distributed in collaboration with related organizations, including the Japan Association of Obstetricians and Gynecologists, Japan Pediatric Association, and Japanese Association of Neuropsychiatric Clinics.
Furthermore, the project will be presented at the 78th Annual Congress of the Japan Society of Obstetrics and Gynecology (May 15–17, 2026, Sapporo) as part of a session organized by the Committee on Women's Health Care titled:
“Commentary on the Clinical Practice Guidance for PMS and PMDD.”
We also aimed to promote the use of these materials in schools, healthcare institutions, and community pharmacies to facilitate broader public awareness and improve the understanding of PMS and PMDD across society.
7.4. Conclusion
The development and dissemination of patient‐oriented educational materials based on clinical guidance represents an important step toward improving the diagnosis, management, and societal understanding of PMS and PMDD. This initiative is expected to enhance patient care and public health awareness in Japan through multidisciplinary collaborations and nationwide dissemination strategies.
8. Subcommittee on the Survey of Telemedicine in Obstetrics and Gynecology in Japan
Subcommittee Chairman: Yutaka Osuga
Subcommittee Members: Takeshi Umazume, Yoshimasa Kamei, Chisato Kunitomi, Daisuke Shigemi, Tokumasa Suemitsu, Kazunori Nagasaka, Yasushi Hirota, Tomoko Makabe, and Jota Maki
8.1. Background and Objectives
In obstetrics and gynecology, telemedicine utilizes ICT for various purposes, including real‐time data sharing between doctors (D to D) and online consultations with patients (D to P). Although guidelines and deregulations have advanced the infrastructure, their actual usage remains limited in Japan. A survey conducted in 2023 showed low implementation rates, with only 5.3% of patients and 20.4% of facilities using online care. In the field of obstetrics and gynecology, many patients are young and likely to have a high affinity for ICT. Consequently, improving accessibility to healthcare through online medical care has the potential to enhance health promotion and advance reproductive rights. However, a comprehensive survey of online medical care across the entire field of obstetrics and gynecology has not yet been conducted, leaving the status of its implementation unknown.
8.2. Study Objectives
This study aimed to facilitate the sound development of telemedicine (primarily Doctor‐to‐Doctor online medical care) in the field of obstetrics and gynecology in Japan, with the ultimate goal of formulating guidelines for online medical care on behalf of the Japan Society of Obstetrics and Gynecology. To achieve this, we aimed to clarify the current status of online medical care from the perspective of gynecologists and obstetricians, investigate the limiting factors for facilities where it is not yet implemented, and compile foundational data.
8.3. Methodology
A questionnaire survey targeting the members of the society was conducted using the mailing list of the Japan Society of Obstetrics and Gynecology. The survey assessed the awareness and implementation status of online medical care, exploring the clinical content, current challenges, and future outlook for implementing facilities as well as the reasons for nonimplementation for others. Approval from the University of Tokyo Ethics Committee was obtained in February 2026, and the questionnaire survey was administered with the response period running from March 4 to March 22, 2026.
8.4. Results
Of the total 28.2% respondents, 28.2% were experienced in providing online medical care, while few members had completed the online medical care training provided by the Ministry of Health, Labour and Welfare (MHLW) but had not yet had the opportunity to practice it. No significant difference was noted in the age distribution or proportion of JSOG‐certified specialists between members with and without online medical care experience.
In 2020, when the requirements for online medical care were relaxed due to the COVID‐19 pandemic, the number of members experiencing online medical care surged rapidly (a 167% increase compared with the previous year). Since then, the growth rate has decreased. Members who already implemented online medical care before the COVID‐19 pandemic (2019 and earlier) showed a high rate of regular continuation, whereas those who started care during or after the pandemic showed a lower continuation rate.
Members with experience in online medical care were widely distributed across the country; however, a high concentration was observed in Tokyo. By institutional type, clinics without beds (nonbed clinics) were the most common, followed by general hospitals and university hospitals/advanced treatment hospitals.
The clinical context primarily involved cases with a low necessity for physical examinations or testing, such as prescriptions for OCs/LEPs (low‐dose estrogen‐progestin), regular follow‐up consultations and prescriptions, and communication of test results.
Although online medical care is often implemented as part of patient services owing to its convenience for patients, several issues have been raised. These include low profitability relative to the effort required to set up communication systems and handle accounting administrative tasks, as well as insufficient clinical information obtained from patients.
8.5. Future Plans
A questionnaire survey targeting the general female population has been scheduled to understand the extent to which women utilize online medical care in the field of obstetrics and gynecology and what they expect from it. This survey aims to neutrally capture the utilization status, needs, and comparative evaluations of face‐to‐face consultations.
9. Development of a JSOG Nutrition Checklist for Young Women and Pregnant Women in Japan: Current Status and Future Plans
Subcommittee Chairman: Koichiro Shimoya
Subcommittee Members: Kuniaki Ota, Mariko Ogawa, Tadashi Kimura, Tomomi Kotani, Takashi Sugiyama, Tsuyoshi Takiuchi, Mutsuko Takemasa, and Hirotaka Nishi
Hisashi Masuyama
Collaborators: Makiko Mitsunami and Kumi Okubo
9.1. Background and Purpose
The Women's Healthcare Subcommittee of the JSOG has initiated a project to develop a practical nutritional checklist for young and pregnant women in Japan. This initiative aimed to establish a simple and clinically applicable screening tool that can be used in routine women's healthcare, preconception and early pregnancy care.
Nutritional issues in Japanese women are an important public health concern. In particular, undernutrition and unbalanced dietary intake among young women may affect not only maternal health, but also pregnancy outcomes and the long‐term health of the next generation. Although the FIGO Nutrition Checklist provides an internationally recognized framework for rapid nutritional assessment, its direct application in Japanese women may be limited because of differences in dietary patterns, food culture, and nutritional habits. Therefore, our subcommittee is working toward the development of a JSOG Nutrition Checklist adapted to the Japanese setting while maintaining compatibility with the global concept proposed by the FIGO.
9.2. Current Focus
At present, the subcommittee is refining the checklist framework and identifying items that are clinically meaningful and culturally appropriate for Japanese women. This project was designed to address two target populations: young women before pregnancy and those in early pregnancy.
The central objective of both groups was to evaluate how well the existing FIGO‐based framework reflects the actual dietary patterns in Japan and to determine which additional or modified items should be incorporated into the Japanese version.
9.3. Future Plans for Young Women
For young women, the next step will be a small‐scale consistency study after the questionnaire has been finalized. This study will be conducted at institutions affiliated with the subcommittee members and will mainly target female students in medical and healthcare‐related programs.
The purpose of this phase is to assess the feasibility and consistency of the questionnaire in a population that is accessible, relevant to future preconception care, and suitable for the preliminary validation of the checklist structure.
9.4. Future Plans for Early Pregnancy
Regarding nutrition during early pregnancy, a broader validation study using a mobile application is planned to reach women in the general population. This app‐based approach enables large‐scale data collection and facilitates assessment of the consistency and applicability of the proposed checklist in real‐world settings.
This study is planned as a collaborative project with the Children and Families Agency. Through this app‐based study, we aim to evaluate whether the checklist appropriately captures nutritional status and dietary behavior among women in early pregnancy and whether it can serve as a useful screening tool in routine maternal care.
9.5. Expected Significance
The future direction of this project is to establish a simple, evidence‐based, practical Japanese nutritional checklist for clinical use. In addition to its role as a screening tool, the checklist may function as an educational instrument to improve nutritional awareness among women of reproductive age.
Ultimately, we hope that this initiative will contribute to better nutritional assessment and support in preconception and pregnancy care in Japan while also providing a framework that can be conceptually compared with international approaches.
9.6. Conclusion
In summary, the JSOG Women's Healthcare Subcommittee is currently developing a Japanese version of a nutrition checklist for young and pregnant women, based on the FIGO concept but adapted for Gynecology and Obstetrics concept. Future work will include a small‐scale consistency study among female healthcare students, and a large‐scale app‐based validation study on women in early pregnancy. These efforts are expected to support the establishment of a practical and culturally relevant nutritional assessment tool for women's health care in Japan.
Author Contributions
Takeshi Iwasa: writing – review and editing, writing – original draft, project administration, conceptualization, funding acquisition, supervision, software, investigation, validation. Kanako Yoshida: conceptualization, methodology, data curation, investigation, formal analysis, validation, visualization, resources. Gentaro Izumi: conceptualization, investigation, methodology, validation, visualization, formal analysis, data curation, resources. Yutaka Osuga: conceptualization, investigation, methodology, validation, visualization, formal analysis, data curation, resources. Yasuhito Kato: conceptualization, investigation, methodology, validation, visualization, formal analysis, data curation, resources. Haruhiko Kanasaki: conceptualization, investigation, methodology, validation, visualization, formal analysis, data curation, resources. Kentaro Kurasawa: conceptualization, investigation, methodology, validation, visualization, formal analysis, data curation, resources. Kenjiro Sawada: conceptualization, investigation, methodology, validation, visualization, formal analysis, data curation, resources. Koichiro Shimoya: conceptualization, investigation, methodology, validation, visualization, formal analysis, data curation, resources. Tsuyoshi Higuchi: conceptualization, investigation, methodology, validation, visualization, formal analysis, data curation, resources. Taisuke Mori: conceptualization, investigation, methodology, validation, visualization, formal analysis, data curation, resources. Zen Watanabe: conceptualization, investigation, validation, visualization, methodology, formal analysis, data curation, resources. Mariko Ogawa: conceptualization, investigation, methodology, validation, visualization, formal analysis, data curation, resources.
Funding
This research was conducted as a committee project funded by the Women's Health Care Committee of the Japan Society of Obstetrics and Gynecology (JSOG).
Conflicts of Interest
Takeshi Iwasa is an Editorial Board member of the JOG Journal and the corresponding author of this article. To minimize bias, he was excluded from all editorial decision‐making related to the acceptance of this article for publication. The other authors declare no conflicts of interest.
Acknowledgments
The Women's Health Care Committee of the Japan Society of Obstetrics and Gynecology extends its sincere appreciation to the numerous obstetricians and gynecologists at clinics and general hospitals across Japan who participated in our nationwide surveys and contributed valuable data to this research. We are also deeply grateful to the administrative office of the Japan Society of Obstetrics and Gynecology for their continuous support and coordination throughout the committee's activities.
Data Availability Statement
The data supporting the findings of this study are available from the Japan Society of Obstetrics and Gynecology. Restrictions apply to the availability of the data, which were used under a license for this study. Data are available with permission from the Japan Society of Obstetrics and Gynecology.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data supporting the findings of this study are available from the Japan Society of Obstetrics and Gynecology. Restrictions apply to the availability of the data, which were used under a license for this study. Data are available with permission from the Japan Society of Obstetrics and Gynecology.
